Evidence map›Paper›PMID 30274224›Full record

ArticleMolecules (Basel, Switzerland)2018

Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?

Ivan Malík, Jozef Csöllei, Ivan Solovič, Šárka Pospíšilová, Hana Michnová, Josef Jampílek, Alois Čížek, Iva Kapustíková, Jana Čurillová, Mária Pecháčová and 3 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. NewLife (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Heterocycles in Medicinal Chemistry.Molecules (Basel, Switzerland) · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ivan MalíkDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. malikivan001@gmail.com.
Jozef CsölleiDepartment of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences in Brno, Palackého 1946/1, CZ-612 42 Brno, Czech Republic. csolleij@vfu.cz.
Ivan SolovičClinic for Tuberculosis and Lung Diseases, National Institute for Tuberculosis, Lung Diseases and Thoracic Surgery, Vyšné Hágy, SK-059 84 Vysoké Tatry, Slovakia. solovic@hagy.sk.
Šárka PospíšilováDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. sharka.pospisilova@gmail.com.
Hana MichnováDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. michnova.hana@gmail.com.
Josef JampílekDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. josef.jampilek@gmail.com.ORCID 0000-0003-2003-9052
Alois ČížekClinic for Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackého 1946/1, CZ-612 42 Brno, Czech Republic. cizeka@vfu.cz.
Iva KapustíkováDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. kapustikova@fpharm.uniba.sk.
Jana ČurillováDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. curilova2@uniba.sk.
Mária PecháčováDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. mariapech901@gmail.com.
Jiřina StolaříkováLaboratory for Mycobacterial Diagnostics and Tuberculosis, Regional Institute of Public Health, Partyzánské náměstí 7, CZ-702 00 Ostrava, Czech Republic. Jirina.Stolarikova@zu.cz.
Daniel PecherDepartment of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia. pecher1@uniba.sk.ORCID 0000-0002-9284-1493
Michal OravecGlobal Change Research Institute CAS, Belidla 986/4a, CZ-603 00 Brno, Czech Republic. oravec.m@czechglobe.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to provide a more detailed view on the structure⁻antimycobacterial activity relationship (

Indexed as

Antitubercular AgentsAzepinesCiprofloxacinComputer SimulationDrug DesignEthambutolIsoniazidMicrobial Sensitivity TestsMycobacteriumMycobacterium aviumMycobacterium kansasiiMycobacterium smegmatisMycobacterium tuberculosisOfloxacinOxalatesPhenylcarbamatesAntitubercular AgentsAzepinesCiprofloxacinEthambutolIsoniazidOfloxacinOxalatesPhenylcarbamatesPyrrolidinesdibasic phenylcarbamateselectronic propertieslipophilicityMycobacterium spp.surface tension

Identifiers

PMID30274224
PMCPMC6222509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.